Search Results - "Safavi, Ashkan"
-
1
Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model
Published in Scientific reports (30-11-2021)“…In our previous study, immunoinformatic tools were used to design a novel multiepitope cancer vaccine based on the most immunodominant regions of BORIS…”
Get full text
Journal Article -
2
Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model
Published in Human vaccines & immunotherapeutics (02-01-2021)“…Multiepitope cancer vaccines have gained lots of attention for prophylactic and therapeutic purposes in cancer patients. In our previous study, multiepitope…”
Get full text
Journal Article -
3
Identifying the most effective hydatid cyst fluid fraction for anticancer vaccination of 4T1 breast tumor-bearing mice
Published in International journal of preventive medicine (01-01-2019)“…Background: The hydatid cyst fluid antigens have high homology with cancer cell antigens and also exhibit considerable immunogenicity. Therefore, their…”
Get full text
Journal Article -
4
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches
Published in Vaccine (10-11-2020)“…•The vaccine is composed of immunodominant regions of SARS-CoV-2 non-structural proteins.•Also, the functional region of the spike protein is incorporated in…”
Get full text
Journal Article -
5
C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression
Published in Scientific reports (16-12-2019)“…Different chemical and nanomaterial agents have been introduced for radiosensitizing purposes. However, many researchers believe these agents are far away from…”
Get full text
Journal Article -
6
In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma
Published in Molecular immunology (01-08-2019)“…•The peptide and DNA cancer vaccines consisted of immunodominant fragments of TMEM31 antigen were designed in silico.•The immunodominant fragments were linked…”
Get full text
Journal Article -
7
Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine
Published in International immunopharmacology (01-11-2019)“…Melanoma cells are significantly resistance to the current treatments. Therefore, the best option for high-risk populations is prevention. Recently, many…”
Get full text
Journal Article -
8
Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches
Published in Journal of biomolecular structure & dynamics (22-09-2022)“…Recently, cancer immunotherapy has gained lots of attention to replace the current chemoradiation approaches and multi-epitope cancer vaccines are manifesting…”
Get full text
Journal Article -
9
Spirulina extract enriched for Braun‐type lipoprotein (Immulina®) for inhibition of 4T1 breast tumors' growth and metastasis
Published in Phytotherapy research (01-02-2020)“…Spirulina platensis extracts have exhibited considerable anti‐cancer effects. To investigate the efficacy of the Spirulina extract enriched for Braun‐type…”
Get full text
Journal Article -
10
In Silico Analysis of Synaptonemal Complex Protein 1 (SYCP1) and Acrosin Binding Protein (ACRBP) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer
Published in International journal of peptide research and therapeutics (01-12-2019)“…Multiepitope cancer vaccines are manifesting as the future of breast cancer immunotherapy. In the present study, high immunogenic fragments of synaptonemal…”
Get full text
Journal Article -
11
Immunization using male germ cells and gametes as rich sources of cancer/testis antigens for inhibition of 4T1 breast tumors' growth and metastasis in BALB/c mice
Published in International immunopharmacology (01-09-2019)“…Recently cancer/testis antigens (CTA) have gained lots of attention as targets of immune therapy. However, the therapeutic efficacy of the CTAs single-antigen…”
Get full text
Journal Article